Kathryn Gallaway, MD (@ke_gallaway) 's Twitter Profile
Kathryn Gallaway, MD

@ke_gallaway

34 y/o G2P2 presents w/ insatiable thirst for knowledge of unknown etiology | Philosophy @RiceUniversity | MD @UTSWNews | Associate Medical Director @DAVAOnc

ID: 1558842292605259777

linkhttps://www.linkedin.com/in/kathryn-gallaway-845136236/ calendar_today14-08-2022 15:46:19

958 Tweet

383 Followers

917 Following

Kathryn Gallaway, MD (@ke_gallaway) 's Twitter Profile Photo
Kathryn Gallaway, MD
@ke_gallaway

6 months ago

Dr. David Miklos Stanford BMT & Cell Therapy kicks of Saturday at #DAVAHeme with intriguing update on secondary malignancy post-CD19 CAR nejm.org/doi/full/10.10… In this patient, the secondary TCL cells were present prior to CAR infusion. Novel mechanism for secondary malignancy post-CAR?

Dr. David Miklos <a href="/StanfordBMT_CT/">Stanford BMT & Cell Therapy</a> kicks of Saturday at #DAVAHeme with intriguing update on secondary malignancy post-CD19 CAR nejm.org/doi/full/10.10… In this patient, the secondary TCL cells were present prior to CAR infusion. Novel mechanism for secondary malignancy post-CAR?